Katz, Daniela <br/><br/>
Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor.  [electronic resource] 

 -  Anti-cancer drugs  Jul 2004 
 - 599-602 p.  digital 
<br/><br/> Publication Type: Case Reports; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/01.cad.0000132236.38297.a7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzamides<br/>Biopsy<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Drug Administration Schedule<br/>Follow-Up Studies<br/>Gastrectomy<br/>Gastrointestinal Neoplasms--diagnosis<br/>Humans<br/>Imatinib Mesylate<br/>Intestinal Polyps--diagnosis<br/>Israel<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Invasiveness--diagnostic imaging<br/>Piperazines--administration & dosage<br/>Postoperative Period<br/>Pyrimidines--administration & dosage<br/>Remission Induction--methods<br/>Splenectomy<br/>Stromal Cells--drug effects<br/>Tomography, Spiral Computed<br/>Treatment Outcome